Where does ratiopharm GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ratiopharm GmbH ranks #9,598 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ratiopharm GmbH hold?

ratiopharm GmbH holds 33 US utility patents granted between 2015 and 2020, spanning 13 technology areas.

What is ratiopharm GmbH's Innovation Score?

ratiopharm GmbH has an Innovation Score of 33.8 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ratiopharm GmbH focus on?

ratiopharm GmbH's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 28 patents, ranking #708 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is ratiopharm GmbH's patent grant rate increasing or decreasing?

ratiopharm GmbH's recent grant velocity is -94% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ratiopharm GmbH's patents?

ratiopharm GmbH's patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ratiopharm GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ratiopharm GmbH

USPTO PatentsView assignee record - 33 granted patents across 13 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, ratiopharm ranks #9,598 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 13 technology areas.

#9,598
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.8/100): 14.8
avg claims per patent: -94%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9598 · Foreign Corporation #9,598 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,598/49,997
PHOTO-FINISH iUNU
CPC-FOCUS A61P · 13 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 14.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -94% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: iUNU, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ratiopharm’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (36%) Velocity 0.0 pts (0%) Breadth 12.7 pts (38%) Claim depth 8.9 pts (26%)

Qualcomm Incorporated · highest

85
ratiopharm · this assignee

34
Shenzhen Intellifusion · near

34
SMed-TA/TD · near

34
Wein Holding · near

34
Zwipe AS · near

34
3D Lighting… · lowest

7

What this shows ratiopharm's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for ratiopharm?

Each dot is one of ratiopharm’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ratiopharm’s own 14.8 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

ratiopharm vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ratiopharm's grants concentrate

ratiopharm GmbH is a focused PatentsView assignee: 13 CPC subclasses with 84.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (10 grants) versus a trough of 2 in 2020. By volume, ratiopharm sits between ZixCorp Systems, Inc. and AB Sandvik Coromant.

Zixcorp Systems

33
Zoosk

33
Zume

33
iunu

33
ratiopharm ◀

33
7AC

32
8×8

32
9224-5489 Quebec

32
AB Sandvik Coroma…

32

What this shows ratiopharm holds 33 patents at rank #9,681, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ratiopharm

By rank, the assignees closest to #9,681 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in ratiopharm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ratiopharm, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), ratiopharm ranks #708 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Shenzhen Intellifusion Technologies Co., Ltd. 34 SMed-TA/TD, LLC 34 Zwipe AS 34 Wein Holding, LLC 34

ratiopharm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ratiopharm GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	30.3%
2016	10	30.3%
2017	4	12.1%
2018	4	12.1%
2019	3	9.1%
2020	2	6.1%

Which technologies does ratiopharm GmbH patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C07D - Heterocyclic Compounds 14

C07C - Acyclic OR Carbocyclic Compounds 12

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 7

Y10T - Technical Subjects Covered BY Former US Classification 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07K - Peptides 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

B01D - Separation 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ratiopharm GmbH's patent record in context - here's where to go next.

ratiopharm GmbH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,598 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ratiopharm GmbH against ZixCorp Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.